Yes CDiddy, Covid will bring a lot of attention to CYDY whether we are approved or not and I sure as heck hope we do get approval. But, with all those new eyes on us from what we did with Covid-19, that will bring a lot more attention to us for all our other indications and I have my hopeful eyes on NASH which continues to make people sick from liver problems and Fibrosis as well as the potential of the many CCR5 cancer indications and not to forget the possibilities of other inflammatory diseases and the list can go on and on and on if you know what I mean.

Good post CDiddy & GLTU

HCIT